...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Combo with Enzalutamide in Phase 2 Metastatic Prostate Cancer Clinical Trial and with Pfizer’s PARPi, talazoparib, in Phase 1b/2 Triple Negative Breast Cancer Trial

Free
AGORACOM NEWS FLASH

New Client Alert!!!

AGORACOM Welcomes TransCanna (TCAN:CSE) Developing The Largest Multi-Purpose Cannabis Facility in California

  • $2M CAD Revenue April 2020
  • $24.6M CAD Revenue Run Rate solely from TransCanna test facility
  • $90M Annual Revenue expected from first full year upon completion of 196,000 Sq Ft Daly facility Q3 2021
  • Daly facility will be one of the largest cannabis facilities in California
  • Recently acquired two California companies,
    • High-end award winning edible producer Soldaze
    • Premium indoor cultivator and distributer Lyfted Farms
  • Lyfted Farms products sold in select Cookies Locations - The most recognizable name in high-end Cannabis.
  • 2019 California Cannabis sales over $3B, industry currently fragmented
  • Direct to dispensary model, cutting out the middleman

Transcanna dark

Hub On AGORACOM / Read Release

 

Message: BIO Investor Forum, Oct 22-23

,,,hummm,,,is there any chance some of our oncology trial data will accompany these presentations??........it probably matters not short term cuz we really are held at arms length from our shares,,,,,,,,yet,,,some nice data would add a special touch to these Fall colors at this time of year,,,and before Xmas,,,,,,,,,and 2020.,,,,,

Share
New Message
Please login to post a reply